IBDEI1E0 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23140,1,4,0)
 ;;=4^C92.00
 ;;^UTILITY(U,$J,358.3,23140,2)
 ;;=^5001789
 ;;^UTILITY(U,$J,358.3,23141,0)
 ;;=C92.40^^110^1097^30
 ;;^UTILITY(U,$J,358.3,23141,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23141,1,3,0)
 ;;=3^Promyelocytic Leukemia,Acute,Not in Remission
 ;;^UTILITY(U,$J,358.3,23141,1,4,0)
 ;;=4^C92.40
 ;;^UTILITY(U,$J,358.3,23141,2)
 ;;=^5001801
 ;;^UTILITY(U,$J,358.3,23142,0)
 ;;=C92.50^^110^1097^27
 ;;^UTILITY(U,$J,358.3,23142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23142,1,3,0)
 ;;=3^Myelomonocytic Leukemia,Acute,Not in Remission
 ;;^UTILITY(U,$J,358.3,23142,1,4,0)
 ;;=4^C92.50
 ;;^UTILITY(U,$J,358.3,23142,2)
 ;;=^5001804
 ;;^UTILITY(U,$J,358.3,23143,0)
 ;;=C78.7^^110^1097^36
 ;;^UTILITY(U,$J,358.3,23143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23143,1,3,0)
 ;;=3^Secondary Malig Neop Liver & Intrahepatic Bile Duct
 ;;^UTILITY(U,$J,358.3,23143,1,4,0)
 ;;=4^C78.7
 ;;^UTILITY(U,$J,358.3,23143,2)
 ;;=^5001339
 ;;^UTILITY(U,$J,358.3,23144,0)
 ;;=C91.10^^110^1097^4
 ;;^UTILITY(U,$J,358.3,23144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23144,1,3,0)
 ;;=3^Lymphocytic Leukemia B-Cell Type,Chronic,Not in Remission
 ;;^UTILITY(U,$J,358.3,23144,1,4,0)
 ;;=4^C91.10
 ;;^UTILITY(U,$J,358.3,23144,2)
 ;;=^5001765
 ;;^UTILITY(U,$J,358.3,23145,0)
 ;;=D46.9^^110^1097^26
 ;;^UTILITY(U,$J,358.3,23145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23145,1,3,0)
 ;;=3^Myelodysplastic Syndrome,Unspec
 ;;^UTILITY(U,$J,358.3,23145,1,4,0)
 ;;=4^D46.9
 ;;^UTILITY(U,$J,358.3,23145,2)
 ;;=^334031
 ;;^UTILITY(U,$J,358.3,23146,0)
 ;;=C79.31^^110^1097^33
 ;;^UTILITY(U,$J,358.3,23146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23146,1,3,0)
 ;;=3^Secondary Malig Neop Brain
 ;;^UTILITY(U,$J,358.3,23146,1,4,0)
 ;;=4^C79.31
 ;;^UTILITY(U,$J,358.3,23146,2)
 ;;=^5001347
 ;;^UTILITY(U,$J,358.3,23147,0)
 ;;=C79.32^^110^1097^34
 ;;^UTILITY(U,$J,358.3,23147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23147,1,3,0)
 ;;=3^Secondary Malig Neop Cerebral Meninges
 ;;^UTILITY(U,$J,358.3,23147,1,4,0)
 ;;=4^C79.32
 ;;^UTILITY(U,$J,358.3,23147,2)
 ;;=^5001348
 ;;^UTILITY(U,$J,358.3,23148,0)
 ;;=G89.3^^110^1097^28
 ;;^UTILITY(U,$J,358.3,23148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23148,1,3,0)
 ;;=3^Neoplasm Related Pain
 ;;^UTILITY(U,$J,358.3,23148,1,4,0)
 ;;=4^G89.3
 ;;^UTILITY(U,$J,358.3,23148,2)
 ;;=^5004159
 ;;^UTILITY(U,$J,358.3,23149,0)
 ;;=C79.82^^110^1097^35
 ;;^UTILITY(U,$J,358.3,23149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23149,1,3,0)
 ;;=3^Secondary Malig Neop Genital Organs
 ;;^UTILITY(U,$J,358.3,23149,1,4,0)
 ;;=4^C79.82
 ;;^UTILITY(U,$J,358.3,23149,2)
 ;;=^267339
 ;;^UTILITY(U,$J,358.3,23150,0)
 ;;=I50.9^^110^1098^7
 ;;^UTILITY(U,$J,358.3,23150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23150,1,3,0)
 ;;=3^Heart Failure,Unspec
 ;;^UTILITY(U,$J,358.3,23150,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,23150,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,23151,0)
 ;;=I73.9^^110^1098^13
 ;;^UTILITY(U,$J,358.3,23151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23151,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,23151,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,23151,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,23152,0)
 ;;=I35.0^^110^1098^11
 ;;^UTILITY(U,$J,358.3,23152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23152,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis
 ;;^UTILITY(U,$J,358.3,23152,1,4,0)
 ;;=4^I35.0
 ;;^UTILITY(U,$J,358.3,23152,2)
 ;;=^5007174
 ;;^UTILITY(U,$J,358.3,23153,0)
 ;;=I35.1^^110^1098^10
 ;;^UTILITY(U,$J,358.3,23153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23153,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Insufficiency
